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Abstract
Background: Minimizing the number of muscle biopsies has important methodological implications and
minimizes subject discomfort during a stable isotope amino acid infusion. We aimed to determine the reliability of
obtaining a single muscle biopsy for the calculation of muscle protein fractional synthetic rate (FSR) as well as the
amount of incorporation time necessary to obtain that biopsy after initiating a stable isotope infusion (Study 1).
The calculation of muscle protein FSR requires tracer steady-state during the stable isotope infusion. Therefore, a
second aim was to examine if steady-state conditions are compromised in the precursor pools (plasma free or
muscle intracellular [IC]) after ingestion of a tracer enriched protein drink and after resistance exercise (Study 2).
Methods: Sixteen men (23 ± 3 years; BMI = 23.8 ± 2.2 kg/m
2, means ± SD) were randomized to perform Study 1
or Study 2 (n = 8, per study). Subjects received a primed, constant infusion of L-[ring-
13C6]phenylalanine coupled
with muscle biopsies of the vastus lateralis to measure rates of myofibrillar protein synthesis (MPS). Subjects in
Study 2 were fed 25 g of whey protein immediately after an acute bout of unilateral resistance exercise.
Results: There was no difference (P = 0.3) in rates of MPS determined using the steady-state precursor-product
equation and determination of tracer incorporation between sequential biopsies 150 min apart or using plasma
protein as the baseline enrichment, provided the infusion length was sufficient (230 ± 0.3 min). We also found that
adding a modest amount of tracer (4% enriched), calculated based on the measured phenylalanine content of the
protein (3.5%) in the drink, did not compromise steady-state conditions (slope of the enrichment curve not
different from zero) in the plasma free or, more importantly, the IC pool (both P > 0.05).
Conclusions: These data demonstrate that the single biopsy approach yields comparable rates of muscle protein
synthesis, provided a longer incorporation time is utilized, to that seen with a traditional two biopsy approach. In
addition, we demonstrate that enriching protein-containing drinks with tracer does not disturb isotopic steady-
state and thus both are reliable techniques to determine rates of MPS in humans.
Introduction
A common approach to quantify rates of skeletal muscle
protein synthesis is to administer a primed continuous
intravenous infusion of an isotopically labelled tracer
amino acid with sequential muscle biopsies to determine
the tracer incorporated into the product (e.g., muscle
protein) over time [1]. The increment in tracer enrich-
ment is divided by the precursor pool tracer enrichment
f r o m :p l a s m af r e ea m i n oa c i d ,t h et i s s u ei n t r a c e l l u l a r
free amino acid (IC), or aminoacyl-tRNA (if obtainable)
pool, to determine the fraction of the muscle protein
pool that has been synthesized per hour [2]. However,
under certain circumstances (e.g. methodological and/or
ethical) it may be necessary to try to avoid this ‘classic’
sequential biopsy approach and instead determine mus-
cle protein FSR from a single biopsy.
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validity of an approach that used one muscle biopsy
instead of the traditional sequential biopsy technique to
determine the fractional synthetic rate (FSR) of muscle
protein in human volunteers. These authors concluded
that a single biopsy led to unreliable rates of muscle
protein synthesis [3]. This conclusion was arrived at by
assuming zero background as the initial enrichment and
infusing a deuterated tracer. Previous investigations have
infused carbon-labelled tracers and gas chromatography-
combustion-isotope ratio mass spectrometry (GC-C-
IRMS) as the primary analytical method to determine
rates of muscle protein synthesis using the single biopsy
approach, and the rates reported were physiologically
interpretable [4-8]. An important distinction between
these investigations [4-8] and that of Smith et al. [3] is
that former studies utilized the initial enrichment from
a body protein as a baseline measure, such as proteins
isolated from plasma [4-6,8] or skin [7], and these inves-
tigations did not assume zero background for the initial
enrichment. As a matter of fact, it has been determined
that plasma protein enrichment more accurately reflects
the pre-infusion enrichment of muscle protein [9]. How-
ever, this approach does necessitate that subjects have
not received
13C tracer infusion as it relies on uniform
labelling of amino acids incorporated into muscle pro-
tein [9]. Admittedly, the reliability of calculating rates of
muscle protein synthesis using
13Cb a c k g r o u n de n r i c h -
ment of a mixed plasma protein pellet coupled with a
single biopsy obtained some time later has never been
directly tested against the standard sequential biopsy
technique. Moreover, it is unknown if the amount of
tracer incorporation time allotted (i.e. short vs. long
incorporation time) before obtaining the single biopsy
will influence muscle protein FSR.
Our laboratory [4,6,8,10] and others [11-17] have a
long standing interest in determining the FSR of muscle
proteins after different acute exercise and feeding inter-
ventions. Therefore, a secondary aim of the investigation
was to study the effects of ingesting a tracer enriched
protein drink immediately after exercise on steady-state
enrichments in the precursor pools (plasma free and IC
pools). Specifically, steady-state precursor-product calcu-
lations can be used so long as a steady state enrichment
of the amino acid tracer occurs in the precursor pools
during the experiment. However, feeding protein would
perturb steady state due to the introduction of exogen-
ous unlabelled trace amino acids during the infusion. To
reduce this possibility with a bolus protein feeding, we
have added crystalline tracer to the protein drink
(matched to the tracee amino acid concentration in the
ingested protein at a level consistent with the predict-
able plasma free and IC pool enrichments) to minimize
dilution of the tracer in the precursor pools and
maintain steady-state enrichment [4,6,8,18]. However,
the validity of such an approach, in maintaining precur-
sor tracer steady-state enrichment, has recently been
brought into question [19].
Indeed, it has been demonstrated that intact protein
and free amino acids (i.e., tracer) have differential intest-
inal absorption kinetics such that the tracer will appear
in the blood before the amino acids derived from the
intact protein [20]. Further, if large quantities of crystal-
line tracer, greater than the abundance of the tracee in
the ingested protein, are ingested measurements of
whole body proteolysis and synthesis are falsely changed
[20]; however, these results are only for whole-body
kinetics [20]. This finding [20] has been suggested to
invalidate the utilization of steady-state equations to cal-
culate muscle protein FSR and ultimately yield flawed
values [19]; however, this supposition has never been
directly tested with a measurement of muscle protein
FSR.
The purpose of this investigation was to test the relia-
bility of commonly used, but recently questioned,
approaches in tracer research for the determination of
muscle protein FSR. Our first objective was to test the
reliability of determining muscle protein FSR from
mixed plasma protein and a single muscle biopsy. We
also wished to determine if there is an optimal amount
of incorporation time that should elapse before obtain-
ing the single biopsy to reliably calculate muscle protein
FSR. Our secondary objective was to improve the tem-
poral resolution of the appearance of the tracer into sys-
temic circulation after ingestion of a protein drink, with
the tracer added as an appropriate fraction of the exo-
genously ingested protein, to examine if steady-state
conditions are compromised, both in the plasma free
and IC pools, after an acute bout of resistance exercise.
Methods
Subjects
Sixteen recreationally active males volunteered to parti-
cipate in the study. All participants were deemed healthy
based on their responses to a routine medical screening
questionnaire.
Ethics statement
All subjects were informed of the purpose of the study,
the experimental procedures involved and all the poten-
tial risks involved before obtaining written consent. This
study was approved by the local Health Sciences
Research Ethics Board of McMaster University and con-
formed to standards for the use of human subjects in
research as outlined in the fifth Declaration of Helsinki
and with current Canadian Tri-council government
funding agency guidelines for use of human subjects in
research [21].
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Subjects were randomized to perform study 1 (the one
biopsy approach confirmation experiment) or study 2
(i.e., the steady-state confirmation experiment) such that
n = 8 was utilized for each study (Figure 1). Subjects
were asked to adhere to their regular diets and refrain
from physical activity for three days prior to the infusion
protocols.
Study 1: One biopsy approach validation experiment
Subjects (n = 8; 21 ± 4 years; BMI = 24.2 ± 2.8 kg/m
2,
means ± SD) reported to the laboratory at 0700 in the
post-absorptive state and a catheter was inserted into a
vein in the hand. A baseline blood sample was drawn
before a 0.9% saline drip was started to keep the cathe-
ter patent for repeated blood sampling. A second cathe-
ter was inserted in the opposing arm for the primed-
constant infusion of L-[ring-
13C6]phenylalanine (prime:
2 μmol∙ kg
-1;0 . 0 5μmol∙ kg
-1 ∙min
-1; Cambridge Isotope
Laboratories Inc., Andover, MA, USA). The utilization
of a single tracer to assess the reliability of the single
biopsy approach allowed us to eliminate any potential
variability shown to exist when making comparison
between different tracers [22]. Muscle biopsies were
obtained 90 min and 240 min after the start of the infu-
sion. Myofibrillar protein synthesis rates were calculated
from the biopsies obtained at 90 min and 240 min
( 2 B X ) .T h em u s c l eb i o p s yo b t a i n e da t9 0m i na n dt h e
mixed plasma protein fraction was used to assess the
reliability of calculating rates of myofibrillar protein
synthesis against the 2BX approach when utilizing a
short incorporation time interval (1BX SHORT),
whereas, the muscle biopsy obtained at 240 min was
used to determine the reliability of a long incorporation
time interval (1BX LONG). Blood samples were drawn
every hour (Figure 1a). All experimental procedures for
t h i ss t u d yw e r ep e r f o r m e dw i t h i nt h es a m eg r o u po f
subjects.
Study 2: Steady-state confirmation experiment
Subjects (n = 8; 22 ± 3 years; BMI = 23.2 ± 2.0 kg/m
2,
means ± SD) reported to the laboratory at 0700 in the
post-absorptive state and the infusion was initiated
according to study 1. A steady-state blood was obtained
(Figure 1b) and subsequently subjects performed an
acute bout of unilateral resistance exercise in which one
leg performed a bout that consisted of 3 sets of 10-12
repetitions of leg press (MAX-1500 by Maxam, Hamil-
ton, ON, Canada) and knee extension machine (Badger
2001 series by Magnum Fitness Systems, South Milwau-
kee, WI, USA) at their previously established 12 repeti-
tion maximum with 2 min rest between sets (EX-FED).
The contralateral leg served as a non-exercised (i.e.,
resting) control (FED). After completion of the exercise
bout, subjects consumed a drink containing 25 g of
whey protein isolate (table 1). To minimize disturbances
in isotopic equilibrium, the drinks were enriched to 4%
with tracer according to a measured phenylalanine con-
tent of 3.56% in the whey protein (i.e., 0.04 × [0.0356 ×
25 g] = 35.6 mg). Based on previous observations from
our laboratory demonstrating that enriching protein
drinks to 6 - 8% with crystalline tracer can cause a tran-
sient spike in blood enrichment, which did not disrupt
steady-state conditions in the intracellular pool, immedi-
ately after drink consumption [4,6,18,23,24]. We instead,
in this study, chose to use a lower tracer enrichment at
a level of 4% tracer drink enrichment based on some
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Figure 1 Study protocol utilized for study 1 for the one biopsy
approach validation. (A) and study 2 for steady-state confirmation
(B). Double arrows indicate bilateral biopsies were obtained at
corresponding time points. During study 2, blood samples were
obtained every 60 min; however, blood sampling was increased to
every 10 min for 120 min after protein drink consumption and
return to 60 min blood sampling thereafter.
Table 1 Essential amino acid content of protein drinks in
study 2
Essential Amino Acids g/100 g
Isoleucine 5.4
Leucine 12.0
Lysine 10.8
Methionine 2.3
Phenylalanine 3.5
Threonine 4.4
Tryptophan 2.7
Valine 5.5
The numbers represent quantities in per 100 g (biPro, Davisco Foods, Le
Sueur, MN, USA).
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tion of blood and intracellular pools with lower tracer
enrichments. Bilateral muscle biopsies were obtained at
60, 180, and 300 min post-exercise recovery. All muscle
biopsies were obtained from the vastus lateralis and
performed with a Bergström needle with procedures
previously described [4,5,18]. Arterialized blood samples
were drawn from a hand vein, which was warmed in a
box heated to 60°C every 1 h in the fasted-state and
every 10 min in the fed-states (Figure 1b) and processed
as previously described [10]. All experimental proce-
dures for this study were performed within the same
group of subjects.
Plasma analyses (Study 1 and 2)
Mixed plasma proteins were extracted from 200 μlo f
plasma by adding 500 μl of acetonitrile. The samples
were spun at 10000 × g f o r5m i na t4 ° Ca n dt h er e s u l -
tant supernatants were removed. The pellets were
washed with 500 μl of distilled water and spun at 10000
× g for 5 min at 4°C. Supernatants removed and the
protein pellets were washed twice more with 70% etha-
nol and lyophilized to dryness. Amino acids were liber-
ated from the mixed plasma proteins by adding 1.5 ml
of 6 M HCL and heated at 110°C for 24 h. Plasma [ring-
13C6] phenylalanine enrichments were determined as
previously described [25]. Blood amino acid concentra-
t i o n sw e r ea n a l y s e db yH P L Ca sp r e v i o u s l yd e s c r i b e d
[26].
Muscle analyses
Myofibrillar enriched proteins were isolated as pre-
viously described [5]. Amino acids were liberated by
a d d i n g1 . 5m lo f6м HCl and heating to 110°C for 24
h. Free amino acids were purified using cation exchange
chromatography (Dowex 50WX8-200 resin; Sigma-
Aldrich Ltd) and converted to their N-acetyl-n-propyl
ester derivatives for analysis by GC-C-IRMS (Hewlett
Packard 6890; IRMS model Delta Plus XP, Thermo Fin-
nigan, Waltham, MA, USA). Derivatized amino acids
were separated on a 30 m × 0.25 mm × 0.25 μmD B - 5
column (temperature programme: 110°C for 2 min; 10°
C∙min-
1 ramp to 240°C; 60°C∙min-
1 ramp to 300°C; hold
for 5 min) prior to combustion. The isotopic abun-
dances were expressed as the delta notation, δ
13Cp e r
mil (‰) deviation from Pee Dee Belemnite (PBD) stan-
dard. Each sample was measured at least three times
with a coefficient of variation always less than 2%.
Intracellular amino acids (IC) were extracted from a
separate piece of wet muscle (~20 mg) with ice-cold 0.6
м perchloric acid. Muscle was homogenized on ice with
a Teflon-coated pestle and then centrifuged at 10000 ×
g for 10 min at 4°C. The supernatant was then collected
and this process was repeated two more times. All three
supernatants were combined and taken as the IC and
purified by cation-exchange chromatography and con-
verted to their heptafluorobutyric (HFB) derivatives
before analysis by GC-MS (models 6890 GC and 5973
MS; Hewlett-Packard, Palo Alto, CA, USA). Intracellular
phenylalanine enrichment was determined using elec-
tron-impact ionization by monitoring ions 316 and 322
(m +0 and m +6, respectively).
Calculation
The fractional synthetic rates (FSR) of myofibrillar pro-
teins were calculated using the standard precursor-pro-
duct method (Study 1):
FSR (%h
−1)=E p2 − Ep1/Eic × 1/t × 100
For short tracer incorporation (1BX SHORT) determi-
nation, Ep2 and Ep1 are the protein bound enrichments
f r o mam u s c l eb i o p s ya t9 0m i na n dp l a s m ap r o t e i n s ,
respectively (see Figure 1A). For long tracer incorpora-
tion (1BX LONG), Ep2 and Ep1 are the protein bound
enrichments from a muscle biopsy at 240 min and
plasma proteins (see Figure 1A). For the two biopsies
(2BX), Ep2 and Ep1 are the protein bound enrichments
from a muscle biopsy at 240 min and a muscle biopsy
at 90 min (see Figure 1A). The difference represents the
change in bound protein enrichment between two time
points; Eic is the mean intracellular phenylalanine
enrichment from the biopsies; and t is the tracer incor-
poration time.
The δ per mil value (
13C‰) was calculated using the
(
13C/
12C) ratio of samples and the standard (Std) CO2
reference gas in the equation:
δ13C‰ = [(13C/12Cs a m p l e )− (13C/12CS t d ) / ( 13C/12CS t d ) ]× 10−3
Where, the standard is referenced to the international
PDB standard.
Statistics
Differences in myofibrillar protein synthesis were
tested by a one-factor (condition) analysis of variance
(ANOVA) with repeated measures. Plasma free
enrichments and blood amino acid concentrations
were analyzed using one-factor (time) repeated mea-
sures ANOVA. Linear regression analyses were per-
formed to assess the existence of a linear fit between
variables. Pearson’s r product moment correlation was
used to examine the relationship between different
variables. Tukey’s post hoc test was performed to
determine differences between means for all signifi-
cant main effects and interactions. For all analyses,
differences were considered significant at P < 0.05. All
results are presented as means ± standard deviation
(SD).
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Study 1: Single biopsy approach validation
Plasma and muscle intracellular free phenylalanine
enrichment
Linear regression analysis revealed that the slopes of the
plasma free enrichments over time curve (i.e. between
60 - 240 min) were not significantly different from zero
(P = 0.30). Further, muscle IC enrichments were not sig-
nificantly different (P = 0.60) from each other at biopsy
time 1 (60 min: 0.037 ± 0.01 tracer·tracee
-1)a n dt i m e2
(240 min: 0.040 ± 0.01 tracer·tracee
-1). Thus, appropriate
conditions were met for the application of the steady-
state precursor product equation. Coefficients of varia-
tion in tracer enrichment over the duration of the infu-
s i o ni nt h ep l a s m af r e ea n dI Cp o o l sa f t e rd r i n k
consumption were 12 ± 2.8 and 6 ± 2.8%, respectively.
Myofibrillar protein bound enrichments
The
13C phenylalanine enrichments expressed as the dif-
ference (δ) from the PDB standard for plasma protein,
time 1 biopsy, and time 2 biopsy were -28.424 ± 0.3,
-27.416 ± 0.4, and -26.626 ± 0.8 (δ
13CPDB), respectively.
The δ
13CPDB difference between sequential biopsies was
0.789 ± 0.1. The δ
13CPDB difference between plasma
protein enrichment and time 1 biopsy was 1.009 ± 0.3.
The δ
13CPDB difference between plasma protein enrich-
ment and biopsy at time 2 was 1.798 ± 0.6.
Myofibrillar protein synthesis
Myofibrillar protein synthesis rates were not different
(Figure 2; P = 0.3) between 1BX LONG and 2BX and
were correlated (Figure 3; r = 0.9, P = 0.003). The inter-
cept for the linear regression of best fit between 1BX
LONG with 2BX was 0.01 ± 0.001 and the slope of this
regression was 0.6 ± 0.1. The percent and absolute
changes in rates of myofibrillar protein synthesis
between 1BX LONG and 2BX were 23 ± 8% and 0.007
± 0.005%/hr, respectively. However, 1BX SHORT was
significantly different from 1BX LONG (P = 0.002) and
2BX (P < 0.001). There was no relationship between
1BX SHORT and 2BX (r = -0.2, P = 0.6). The percent
and absolute differences in rates of myofibrillar protein
synthesis between 1BX SHORT and 2BX were 61 ± 21%
and 0.024 ± 0.012%/hr, respectively.
Study 2: Steady-state confirmation
Plasma and muscle intracellular free phenylalanine
enrichment
Plasma free and muscle intracellular free phenylalanine
enrichments are shown in Figure 4, A and 4B, respec-
tively. Plasma free enrichments were significantly differ-
ent (P < 0.001) from pre-drink ingestion at 20 min after
drink ingestion. However, linear regression analysis indi-
cated that the slopes of the plasma free enrichments
over time were not significantly different from zero (P =
0.8), suggesting that plas m af r e ee n r i c h m e n t sh a d
reached a plateau and subjects were at isotopic steady-
state over the duration of the infusion. Moreover, the
slope of the intracellular phenylalanine enrichment (i.e.,
the precursor pool used in all of our previous studies)
by time curve for both FED and EX-FED was not differ-
ent from zero (P = 0.4 and 0.7, respectively), giving
further confirmation that steady-state conditions were
achieved. Coefficients of variation in tracer enrichment
after drink consumption in the plasma free (i.e. from
fast to 180 min; Figure 4A) and IC pools (i.e. from 60 -
300 min; Figure 4B) were 12 ± 2% and 6 ± 2%,
respectively.
Blood amino acid concentrations
Essential amino acid (EAA) concentrations are shown in
Figure 5. Protein ingestion induced a significant rise in
EAA concentration at 50 min and this elevation was
maintained until 110 min (all, P < 0.05).
Discussion
The present study demonstrates that using proteins iso-
lated from plasma for baseline enrichments, coupled
with a carbon-based tracer and analysis of protein from
as i n g l em u s c l eb i o p s yb yG C - C - I R M S ,s e r v e sa sar e l i -
able alternative to obtaining two biopsies for the calcula-
tion of myofibrillar protein synthesis. However, the
length of this initial incorporation period needs to be
considered with the one biopsy approach. As a rule, the
reliability of the single biopsy approach is dependent on
the use of subjects who have never received tracer
before participation in the study (i.e. “tracer naїve”)a s
the muscle, due to its slow turnover, will have residual
tracer enrichments remaining from previous infusion
experiments. To the authors’ knowledge it remains to be
systematically investigated the length of time in which
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Figure 2 Myofibrillar protein fractional synthetic rate (FSR)
calculated by. 1) utilizing plasma protein enrichment and a short
incorporation time (90 min; 1BX SHORT), 2) utilizing plasma protein
and a long incorporation time (240 min; 1BX LONG), or 3) utilizing
sequential muscle biopsies (2BX) in study 1. *Significantly different
from 2BX, P < 0.001. †Significantly different from 1BX LONG, P =
0.002. Values are means ± SD; n = 8
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Page 5 of 913C muscle enrichments return to pre-infusion values;
however, such an effect could take years and contain
substantial between-subject variations based on age or
activity level. Thus, we do not know the time required
to reinstate a participant into a tracer infusion protocol
that employed the single biopsy approach.
It is clear that assuming zero background enrichment
to calculate rates of muscle protein synthesis is an egre-
gious approach [3] and should not be confused with the
technique employed in the current study (i.e., plasma
protein for baseline enrichment), which we have used
previously [4-6]. The finding that a short incorporation
period (i.e., 1BX SHORT) results in inflated rates of
myofibrillar protein synthesis arises from the fact that a
1.009 δ
13CPDB change occurred from the plasma protein
13C enrichments during a short time frame (i.e., 88
min). This finding is not entirely surprising as there can
be considerable variation, in our hands, between sub-
jects in the change in muscle enrichments (i.e. δ
13CPDB)
when attempting to calculate FSR during 0 - 1 h time
intervals. Therefore, it is likely an artifact of the
a p p r o a c ha n di ti sp o s s i b l et h a tt h i sa r i s e sf r o mt h e
non-steady state conditions that existed in the initial
period after initiating the infusion. However, this effect
becomes trivial over a larger time interval (3 h) of incor-
poration (i.e., 1BX LONG). It should be acknowledged
that protein-bound tracer enrichments can be derived
by using GC-MS; however, when utilizing a deuterated
tracer (e.g.[
2H5]phenylalanine), the amino acid derivative
is especially vulnerable to isotope effects during frag-
mentation inside the ionization source during analysis
[27]. These non-equating ion abundance ratios can be
corrected by a standard curve to better represent the
true tracer-to-tracee ratio [27], but this would not be
possible in a baseline sample in which no tracer (i.e., a
detectable m+5 or an m+6 ion using GC-MS for analy-
sis) is present. Therefore, the current study is specific to
carbon-based tracers and utilizing GC-C-IRMS to deter-
mine the enrichments of the labelled amino acid in the
plasma protein bound sample.
It is important to highlight that the 1BX LONG con-
dition did result in slightly elevated myofibrillar protein
synthesis rates, although not statistical significant, from
that of the 2BX that may arithmetically influence the
relative change in FSR observed after a feeding and/or
an exercise stimulus (i.e. the observed difference may be
slightly less than that observed after the 2BX condition).
Regardless, we have detected robust changes in muscle
protein FSR after feeding 15 g of whey protein at rest
[23], resistance exercise in the fasted-state [5], and after
a combined feeding and exercise stimulus [4,6], which
further demonstrates that it is possible to detect changes
in FSR with the 1BX LONG approach. However, under
certain circumstances, where large increases in muscle
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Figure 3 The relationship between obtaining sequential muscle biopsies (2BX) and utilizing the single biopsy approach with a long
incorporation time (1BX LONG) in study 1. There was a significant (r = 0.9, P = 0.003) correlation between rates of myofibrillar protein
synthesis (FSR, %/hr) using the 2BX and 1BX LONG approaches. Dark line: line of linear best fit, with 95% confidence interval, for 1BX LONG
versus 2 BX - y = 0.64 ± 0.16x + 0.01 ± 0.001. Dashed line: line of identity. Note: only 7 points are visible since two points share the same values
(outline in bold).
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Page 6 of 9protein FSR may not be expected (e.g. feeding a minimal
amount of protein to elderly subjects), the 2BX
approach may be worth considering. A final point of
concern was the 1BX LONG produced a muscle protein
FSR that was 23% greater than that observed in the 2BX
condition. However, a sample size of 47 participants
would be necessary to manifest statistically significant
differences between conditions based on power calcula-
tions performed using a two sided statistical test, a false
positive rate of 5%, and a power of 80%.
A second objective of the study was to provide a
direct validate to an approach that we have used to
determine rates of muscle protein synthesis after bolus
protein ingestion to determine protein feeding- and/or
exercise plus protein feeding-induced changes in muscle
protein synthesis [4,6,18]. Specifically, we wished to pre-
sent detailed evidence confirming that adding a small
amount of labelled free amino acids (i.e., tracer) to a
protein drink does not disrupt steady-state conditions in
sampled precursor pools. Here, we established that
steady-state conditions were not substantially disrupted
in the plasma free or, most importantly, the IC protein
pools over the duration of the infusion, as noted by the
slope of the plasma free and IC enrichments by time
c u r v ew e r en o ts i g n i f i c a n t l yd i f f e r e n tf r o mz e r od u r i n g
the infusion. Since an appropriate level of tracer was
added to the protein to prevent ‘over-enriching’ the
drink we did not create a large rise in enrichment to
disturb steady-state conditions, which has been reported
by others [20]. As expected, the coefficients of variation
in the sampled precursor pools for plasma (12%) and IC
free amino acid pools (6%) did illustrate that the plasma
free pool is more ‘vulnerable’ to changes in enrichment
from tracer enriched protein drinks as compared to the
IC pool. It is worth mentioning, however, that we agree
with previous suggestions that it is not advisable to
assess digestion and absorption kinetics by adding tracer
to a protein drink and therefore, intrinsically labelled
dietary proteins are of tremendous value in this regard
[28].
Conclusion
In conclusion, we supply direct evidence demonstrating
that a single biopsy approach, in tracer naїve partici-
pants, serves as a reliable technique compared to obtain-
ing an additional biopsy to determine muscle protein
FSR. This finding has practical significance as it will
minimize the discomfort and associated risk associated
with multiple biopsies. However, based on our data the
tracer incorporation should be long enough (i.e., ~3
hours from our results) to reliably determine rates of
myofibrillar protein synthesis. In addition, adding appro-
priate quantities of crystalline tracer to a bolus protein
drink does not disrupt steady-state conditions and in
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Figure 4 Plasma (A) and muscle intracellular free (B)
phenylalanine enrichments (tracer·Tracee
-1) after resistance
exercise and protein ingestion (EX-FED) or protein ingestion a
lone (FED) in study 2. *Significantly different from pre value, P <
0.001. All values are means ± SD; n = 8.
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Figure 5 Blood concentrations of essential amino acids after
ingestion of 25 g of whey protein isolate in study 2.
*Significantly different from pre value, P < 0.05. All values are means
± SD; n = 8.
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Page 7 of 9fact aids in minimizing perturbations in the most valid
precursor pool (i.e., the IC pool), thus providing appro-
priate conditions for the application of the steady-state
precursor product equation.
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